BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1231 related articles for article (PubMed ID: 24838880)

  • 1. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to generate induced pluripotent stem cells.
    Hayes M; Zavazava N
    Methods Mol Biol; 2013; 1029():77-92. PubMed ID: 23756943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic mRNA Reprogramming of Human Fibroblast Cells.
    Liu J; Verma PJ
    Methods Mol Biol; 2015; 1330():17-28. PubMed ID: 26621585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of Human iPSCs by Protein Reprogramming and Stimulation of TLR3 Signaling.
    Liu C; Ameen M; Himmati S; Thomas D; Sayed N
    Methods Mol Biol; 2021; 2239():153-162. PubMed ID: 33226618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.
    Borgohain MP; Haridhasapavalan KK; Dey C; Adhikari P; Thummer RP
    Stem Cell Rev Rep; 2019 Apr; 15(2):286-313. PubMed ID: 30417242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
    Hussein SM; Nagy AA
    Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A highly optimized protocol for reprogramming cancer cells to pluripotency using nonviral plasmid vectors.
    Zhao H; Davies TJ; Ning J; Chang Y; Sachamitr P; Sattler S; Fairchild PJ; Huang FP
    Cell Reprogram; 2015 Feb; 17(1):7-18. PubMed ID: 25549177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
    Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
    Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of induced pluripotent stem cells.
    Deyle DR
    Methods Mol Biol; 2015; 1226():43-58. PubMed ID: 25331042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced Pluripotent Stem Cells: Generation, Characterization, and Differentiation--Methods and Protocols.
    Graversen VK; Chavala SH
    Methods Mol Biol; 2016; 1357():395-401. PubMed ID: 25403469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells.
    Hu C; Li L
    Regen Med; 2016 Jan; 11(1):105-32. PubMed ID: 26679838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
    Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
    PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprogramming of somatic cells via TAT-mediated protein transduction of recombinant factors.
    Zhang H; Ma Y; Gu J; Liao B; Li J; Wong J; Jin Y
    Biomaterials; 2012 Jul; 33(20):5047-55. PubMed ID: 22494883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells.
    Brix J; Zhou Y; Luo Y
    J Genet Genomics; 2015 Dec; 42(12):661-70. PubMed ID: 26743984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of pluripotency in long-term cryopreserved human neonatal fibroblasts in feeder-free condition.
    Csobonyeiova M; Krajciova L; Nicodemou A; Polak S; Danisovic L
    Cell Tissue Bank; 2017 Mar; 18(1):45-52. PubMed ID: 27873029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells.
    Lu HF; Chai C; Lim TC; Leong MF; Lim JK; Gao S; Lim KL; Wan AC
    Biomaterials; 2014 Mar; 35(9):2816-26. PubMed ID: 24411336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
    Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
    Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.
    Quintana-Bustamante O; Segovia JC
    Methods Mol Biol; 2016; 1353():1-11. PubMed ID: 25523810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.